The Prefilled Auto Injectors Market is poised for robust expansion driven by escalating incidence of chronic conditions, heightened demand for self-administration therapeutics, and intensifying ...

The landscape of weight management has evolved dramatically in recent years, with GLP-1 receptor agonists like Semaglutide leading the way in treating obesity. However, a new contender has emerged: ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

These results once again have the potential to deliver a best in class profile with pivotal data expected this year or next ...

Richmond, VA, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injectors, today announced the appointment of Ram Halthore as Vice President, ...

At a time when Pakistan’s economy faces persistent balance-of-payments pressures, export-led growth is no longer optional. It is essential. In this ...

The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...

Retailers that adapt to these evolving patterns will be better positioned as GLP-1 use becomes more integrated into consumer ...

Wegovy’s oral version of its injectable weight-loss drug is seeing tremendous interest, Novo Nordisk executive Dave Moore told FOX Business on Friday. Wegovy’s once-daily pill, an oral spinoff of its ...